NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared BioFire Diagnostics' FilmArray Blood Culture Identification, or BCID, Panel, the company announced today.

The FDA clearance follows CE marking of the 27-target panel earlier this month. The Salt Lake City company filed its 510(k) submission to FDA for the test in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.